Tofacitinib Degradation impurity, Tofacitinib Process impurity, Tofacitinib Potential impurity, Tofacitinib USP Related Compound, Tofacitinib N-Nitroso impurity, Tofacitinib nitrosamine impurity, N-Oxide, N-Nitroso, Nitrosamine, Chiral, Isomeric Impurities etc. are listed below. Tofacitinib is a Janus kinase (JAK) inhibitor. Tofacitinib works by blocking the action of Janus kinase enzymes, which are involved in inflammation. Tofacitinib is used to treat rheumatic conditions, such as rheumatoid arthritis, and ankylosing spondylitis, and ulcerative colitis. Tofacitinib may decrease your ability to fight infection and increase your risk of serious infection. Tofacitinib belongs to a group of medicines called beta-adrenergic blocking agent. Tofacitinib Degradation impurity, Tofacitinib Process impurity, Tofacitinib Potential impurity, Tofacitinib USP Related Compound, Tofacitinib N-Nitroso impurity, Tofacitinib nitrosamine impurity etc. are listed below.
![(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile L-aspartate | NA | Tofacitinib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA43312.png)
![2-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-2-oxoacetic acid | 2328165-36-0 | Tofacitinib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA43311.png)
![3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]3-oxopropanenitrile-N-Oxide | NA | Tofacitinib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA43309.png)
![Ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate | 1675248-18-6 | Tofacitinib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA43310.png)
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
